Formosa Laboratories Inc
TWSE:4746

Watchlist Manager
Formosa Laboratories Inc Logo
Formosa Laboratories Inc
TWSE:4746
Watchlist
Price: 70 TWD -0.28% Market Closed
Market Cap: 8.4B TWD
Have any thoughts about
Formosa Laboratories Inc?
Write Note

Formosa Laboratories Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Formosa Laboratories Inc
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Formosa Laboratories Inc
TWSE:4746
Retained Earnings
NT$2.8B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
24%
Y
YungShin Global Holding Corp
TWSE:3705
Retained Earnings
NT$2.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
13%
ScinoPharm Taiwan Ltd
TWSE:1789
Retained Earnings
NT$1.3B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
3%
S
SCI Pharmtech Inc
TWSE:4119
Retained Earnings
NT$2B
CAGR 3-Years
22%
CAGR 5-Years
10%
CAGR 10-Years
12%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Retained Earnings
NT$11.6B
CAGR 3-Years
102%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Standard Chem & Pharm Co Ltd
TWSE:1720
Retained Earnings
NT$3.5B
CAGR 3-Years
17%
CAGR 5-Years
17%
CAGR 10-Years
16%
No Stocks Found

Formosa Laboratories Inc
Glance View

Market Cap
8.4B TWD
Industry
Pharmaceuticals

Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

Intrinsic Value
108.78 TWD
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Formosa Laboratories Inc's Retained Earnings?
Retained Earnings
2.8B TWD

Based on the financial report for Sep 30, 2024, Formosa Laboratories Inc's Retained Earnings amounts to 2.8B TWD.

What is Formosa Laboratories Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
24%

Over the last year, the Retained Earnings growth was 6%.

Back to Top